Mark Marriott - Concepedia

Author

Mark Marriott

Also Known As

Ayse Altintas, K Maleki, Luca Mancinelli, M Marriott, M. Marriott, Mark Marriott, Mark P Marriott, Mark P. Marriott, Marriott, M, Pierre Despault

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

The University of Melbourne The Royal Melbourne Hospital Florey Institute of Neuroscience and Mental Health Monash University University of Tasmania

About

Mark Marriott is an author at The University of Melbourne specializing in medicine, neuroimmunology, and multiple sclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	440
2	Public Health	3	3	69
3	Cell Biology	2	2	94
4	Nursing	1	1	17
5	Social Sciences	1	1	46

Mark Marriott

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians Justin P. Rubio, Jim Stankovich, Judith Field, Genes and Immunity ImmunogeneticsDisease SusceptibilityAutoimmune DiseaseImmune Cell DevelopmentGenetics	2008	130
Incidence and prevalence of NMOSD in Australia and New Zealand Wajih Bukhari, Kerri Prain, Patrick Waters, Journal of Neurology Neurosurgery & Psychiatry	2017	120
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial Bruce Cree, Gary Cutter, Jerry S. Wolinsky, The Lancet Neurology	2020	99
Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss Helmut Butzkueven, Ben Emery, Tania Cipriani, Glia	2006	87
Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair Mark Marriott, Ben Emery, Holly S. Cate, Glia	2008	85
MRI identification of the rostral‐caudal pattern of pathology within the corpus callosum in the cuprizone mouse model Qizhu Wu, Qing Yang, Holly S. Cate, Journal of Magnetic Resonance Imaging	2007	80
A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor Anneke van der Walt, Simon Sung, Timothy Spelman, Neurology	2012	77
Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination Ben Emery, Holly S. Cate, Mark Marriott, Proceedings of the National Academy of Sciences ImmunologyCell DeathImmunologic MechanismImmunotherapyNeuroinflammation	2006	75
Expression of the low‐affinity neurotrophin receptor, p75<sup>NTR</sup>, is upregulated by oligodendroglial progenitors adjacent to the subventricular zone in response to demyelination Steven Petratos, Michael Gonzales, Michael F. Azari, Glia	2004	57
Optic Nerve Diffusion Tensor Imaging after Acute Optic Neuritis Predicts Axonal and Visual Outcomes Anneke van der Walt, Scott Kolbe, Yejun E. Wang, PLoS ONE	2013	49

Page 1